MUM-1 (Multiple myeloma oncogene-1), catalog number PRM352 AA; Product Usage: For In Vitro Diagnostic Use. This antibody may be used as a tool for the identification and the sub classification of lymphoid malignancies : Multiple myeloma oncogene-1 (MUM-1) is a protein encoded by MUM-1 gene. MUM-1 protein is expressed in the nuclei and cytoplasm of plasma cells and a small percentage of germinal center (GC) B-cells located in the light zone. MUM-1 [BC5] labels MUM-1protein in centrocytes and their progeny, plasma cells, activated T-cells and a wide spectrum of hematolymphoid neoplasms derived from these cells. MUM-1 has been reported to play an important role in mediating B-cell activation and differentiation.
Published January 21, 2015 · Recall initiated: December 12, 2014
Summary
FDA records medical device Class II recall Z-0965-2015, published January 21, 2015 and initiated December 12, 2014. Recalling firm: Biocare Medical Llc; Status: Terminated; Reported quantity: 59; Lot: Lot 061013, Exp 2016/06; Lot 073013, Exp. 2016/07; Lot 071614, Exp. 2017/07. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Three lots of MUM-1 may not meet their labeled shelf life, as a drop in staining intensity over time has been observed.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Biocare Medical Llc
- Distributor
- Worldwide Distrinution - US Nationwide in the states of TX, WI, MO, WV, SC, MA, WA, TN, AZ, CA, IL, NY, LA and countries of Kuwait, India, Venezuela, New Zealand, Turkey, Uruguay.
- Lot
- Lot 061013, Exp 2016/06; Lot 073013, Exp. 2016/07; Lot 071614, Exp. 2017/07.
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAHeartStart MRx Monitor/Defibrillator; Model. Numbers: M3535A, M3536A, M3536J, M3536M, M3536MC, M3536M2,January 21, 2015
- FDAVITROS 3600 Immunodiagnostic System, Catalog Number 6802783, IVD --- Ortho Clinical Diagnostics. For use inJanuary 21, 2015
- FDAiPlan RT is a radiation treatment planning system that is intended for use in stereotactic, conformal,January 21, 2015
- FDAlnline Persuader- PedFuse Pedicle Screw System; Part Number: 11-80164January 21, 2015
- FDAGE Healthcare, Proteus XR/a with wall stand model number 600-0301.January 21, 2015
- FDATimberline Anchored Lateral Fixed Retractable Sleeve Model No. 8630-0205. Timberline Anchored Lateral FixedJanuary 21, 2015
Questions about this recall
Was MUM-1 (Multiple myeloma oncogene-1), catalog number PRM352 AA; Product Usage: For In Vitro Diagnostic Use. This antibody may be used as a tool for the identification and the sub classification of lymphoid malignancies : Multiple myeloma oncogene-1 (MUM-1) is a protein encoded by MUM-1 gene. MUM-1 protein is expressed in the nuclei and cytoplasm of plasma cells and a small percentage of germinal center (GC) B-cells located in the light zone. MUM-1 [BC5] labels MUM-1protein in centrocytes and their progeny, plasma cells, activated T-cells and a wide spectrum of hematolymphoid neoplasms derived from these cells. MUM-1 has been reported to play an important role in mediating B-cell activation and differentiation. recalled?
Yes. FDA published recall Z-0965-2015 on January 21, 2015. Reported hazard: Three lots of MUM-1 may not meet their labeled shelf life, as a drop in staining intensity over time has been observed.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone